US Bancorp’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-18,925
| Closed | -$408K | – | 4174 |
|
|
2025
Q4 | $408K | Buy |
18,925
+42
| +0.2% | +$815 | ﹤0.01% | 1649 |
|
|
2025
Q3 | $288K | Hold |
18,883
| – | – | ﹤0.01% | 1820 |
|
|
2025
Q2 | $167K | Sell |
18,883
-277
| -1% | -$2.43K | ﹤0.01% | 2143 |
|
|
2025
Q1 | $150K | Buy |
19,160
+910
| +5% | +$7.62K | ﹤0.01% | 2176 |
|
|
2024
Q4 | $192K | Sell |
18,250
-316
| -2% | -$3.84K | ﹤0.01% | 2048 |
|
|
2024
Q3 | $243K | Buy |
18,566
+76
| +0.4% | +$1.16K | ﹤0.01% | 1931 |
|
|
2024
Q2 | $260K | Buy |
18,490
+43
| +0.2% | +$701 | ﹤0.01% | 1852 |
|
|
2024
Q1 | $312K | Sell |
18,447
-35
| -0.2% | -$521 | ﹤0.01% | 1785 |
|
|
2023
Q4 | $261K | Buy |
18,482
+163
| +0.9% | +$1.92K | ﹤0.01% | 1883 |
|
|
2023
Q3 | $189K | Buy |
18,319
+69
| +0.4% | +$924 | ﹤0.01% | 1855 |
|
|
2023
Q2 | $301K | Hold |
18,250
| – | – | ﹤0.01% | 1675 |
|
|
2023
Q1 | $167K | Hold |
18,250
| – | – | ﹤0.01% | 1946 |
|
|
2022
Q4 | $131K | Buy |
18,250
+16,240
| +808% | +$114K | ﹤0.01% | 2082 |
|
|
2022
Q3 | $10K | Buy |
+2,010
| New | +$11.1K | ﹤0.01% | 3362 |
|
|
2022
Q1 | – | Sell |
-325
| Closed | -$3K | – | 4056 |
|
|
2021
Q4 | $3K | Buy |
+325
| New | +$2.97K | ﹤0.01% | 3771 |
|
|
2019
Q4 | – | Sell |
-364
| Closed | -$1K | – | 3648 |
|
|
2019
Q3 | $1K | Buy |
+364
| New | +$911 | ﹤0.01% | 3474 |
|
|
2019
Q2 | – | Sell |
-12,500
| Closed | -$18K | – | 3613 |
|
|
2019
Q1 | $18K | Hold |
12,500
| – | – | ﹤0.01% | 2887 |
|
|
2018
Q4 | $32K | Hold |
12,500
| – | – | ﹤0.01% | 2638 |
|
|
2018
Q3 | $55K | Hold |
12,500
| – | – | ﹤0.01% | 2506 |
|
|
2018
Q2 | $77K | Hold |
12,500
| – | – | ﹤0.01% | 2354 |
|
|
2018
Q1 | $91K | Hold |
12,500
| – | – | ﹤0.01% | 2287 |
|
|
2017
Q4 | $103K | Hold |
12,500
| – | – | ﹤0.01% | 2236 |
|
|
2017
Q3 | $131K | Hold |
12,500
| – | – | ﹤0.01% | 2083 |
|
|
2017
Q2 | $138K | Hold |
12,500
| – | – | ﹤0.01% | 2027 |
|
|
2017
Q1 | $121K | Hold |
12,500
| – | – | ﹤0.01% | 2064 |
|
|
2016
Q4 | $130K | Hold |
12,500
| – | – | ﹤0.01% | 1988 |
|
|
2016
Q3 | $155K | Hold |
12,500
| – | – | ﹤0.01% | 1867 |
|
|
2016
Q2 | $134K | Hold |
12,500
| – | – | ﹤0.01% | 1868 |
|
|
2016
Q1 | $138K | Hold |
12,500
| – | – | ﹤0.01% | 1848 |
|
|
2015
Q4 | $153K | Hold |
12,500
| – | – | ﹤0.01% | 1820 |
|
|
2015
Q3 | $204K | Hold |
12,500
| – | – | ﹤0.01% | 1727 |
|
|
2015
Q2 | $265K | Hold |
12,500
| – | – | ﹤0.01% | 1640 |
|
|
2015
Q1 | $225K | Hold |
12,500
| – | – | ﹤0.01% | 1738 |
|
|
2014
Q4 | $214K | Hold |
12,500
| – | – | ﹤0.01% | 1733 |
|
|
2014
Q3 | $179K | Hold |
12,500
| – | – | ﹤0.01% | 1822 |
|
|
2014
Q2 | $188K | Hold |
12,500
| – | – | ﹤0.01% | 1830 |
|
|
2014
Q1 | $168K | Sell |
12,500
-125
| -1% | -$1.34K | ﹤0.01% | 1858 |
|
|
2013
Q4 | $102K | Buy |
12,625
+125
| +1% | +$882 | ﹤0.01% | 2092 |
|
|
2013
Q3 | $82K | Hold |
12,500
| – | – | ﹤0.01% | 2117 |
|
|
2013
Q2 | $77K | Buy |
+12,500
| New | +$64.6K | ﹤0.01% | 2124 |
|
Other funds holding AVDL
US Bancorp's AVDL Position: Q1 2026 in Review
US Bancorp sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 18,925 shares — an estimated $408K sold.
US Bancorp first reported a position in AVDL in Q2 2013 and held it in 40 quarters. The position peaked at $408K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.
- US Bancorp reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- US Bancorp sold 18,925 Avadel Pharmaceuticals shares in Q1 2026, an estimated $408K.
- US Bancorp first reported a position in Avadel Pharmaceuticals in Q2 2013 and held it in 40 quarters.
- US Bancorp's Avadel Pharmaceuticals position peaked at $408K in Q4 2025.
- 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.
Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.